The Journal of Bone and Joint Surgery (American) 83:S8-18 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
Radiographic and Histologic Assessment of Calcium Sulfate in Experimental Animal Models and Clinical Use as a Resorbable Bone-Graft Substitute, a Bone-Graft Expander, and a Method for Local Antibiotic Delivery
One Institutions Experience
Thomas M. Turner, DVM,
Robert M. Urban,
Steven Gitelis, MD,
Ken N. Kuo, MD and
Gunnar B.J. Andersson, MD
Thomas M. Turner, DVM
Robert M. Urban
Steven Gitelis, MD
Ken N. Kuo, MD
Gunnar B.J. Andersson, MD
Department of Orthopedic Surgery, Rush-Presbyterian-St. Lukes
Medical Center, 1653 West Congress Parkway, 1471 Jelke, Chicago,
IL 60612
In support of their research or preparation of this manuscript, one
or more of the authors received grants or outside funding from Wright
Medical Technology. In addition, one or more of the authors received
payments or other benefits or a commitment or agreement to provide
such benefits from a commercial entity (Wright Medical Technology).
No commercial entity paid or directed, or agreed to pay or direct,
any benefits to any research fund, foundation, educational institution,
or other charitable or nonprofit organization with which the authors
are affiliated or associated.
| The first 150 words of the full text of this article appear below. |
 |
Introduction
|
|---|
For more than a decade, the radiographic and histologic appearance
of a refined calcium sulfate has been studied in various experimental
animal models in our laboratory and in clinical applications. This
report summarizes our institutions experience with calcium
sulfate as a synthetic bone graft1,
a graft expander (the synergistic combination of calcium sulfate
with demineralized bone matrix)2-4,
and a method for local delivery of antibiotics5-8.
Historically, orthopaedic usage of calcium sulfate was popularized
by Peltier. Clinically, we have used calcium sulfate to treat numerous
osseous lesions and conditions occurring in the axial and appendicular
skeleton, including a variety of benign lesions of bone, osseous
defects following implant removal, corrective osteotomy sites, spinal
fusion sites, graft sites, fracture defects, and osteomyelitic lesions.
Both our research studies and clinical experience have shown consistent
osteoconduction, excellent biocompatibility, and complete resorption
of calcium sulfate, which was replaced by newly formed bone . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Technorati What's this?
|